Historical record - last NADAC effective date: 4/23/2014
Product Information
ZYPREXA ZYDIS 15 MG TABLET is a brand product labeled by Eli Lilly and Company, priced at $27.6145 per EA under NDC 00002445585. Its NADAC has been published 56 times since Apr 23, 2014.
FDA first approved this application on Apr 6, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Eli Lilly and CompanyNDC
00002445585
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
4/23/2014
Active Ingredients
OLANZAPINEApproval Type
New Drug (NDA)
FDA Application
NDA021086FDA Approved
4/6/2000
TE Code
AB
On Market Since
9/1/2001
Pharmacological Classes
Price Statistics
The NADAC for ZYPREXA ZYDIS 15 MG TABLET has been published 56 times since Apr 23, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $27.6145 per EA |
|---|---|
| All-time high | $27.6145 (May 13, 2015) |
| All-time low | $27.6145 (Apr 23, 2014) |
| Median price | $27.6145 |
| Average price | $27.6145 |
| Largest weekly change | 0.0% (Apr 30, 2014) |
| Weeks tracked | 56 |
| Tracking since | Apr 23, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed May 13, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eli Lilly and Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Olanzapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZYPREXA ZYDIS 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZYPREXA ZYDIS 15 MG TABLET, manufactured by Eli Lilly and Company, is $27.6145 per EA (NDC 00002445585), effective May 13, 2015.
How has the price of ZYPREXA ZYDIS 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZYPREXA ZYDIS 15 MG TABLET has held within roughly two percent of its current level. It has been tracked across 56 weekly CMS publications since Apr 23, 2014.
What are the highest and lowest recorded NADAC prices for ZYPREXA ZYDIS 15 MG TABLET?
Since Apr 23, 2014, the NADAC for ZYPREXA ZYDIS 15 MG TABLET has ranged from a low of $27.6145 (Apr 23, 2014) to a high of $27.6145 (May 13, 2015), with a median of $27.6145 per EA.
Are there cheaper alternatives to ZYPREXA ZYDIS 15 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLANZAPINE 15 MG TABLET, is $0.1317 per EA — about 99% below ZYPREXA ZYDIS 15 MG TABLET.
Who manufactures ZYPREXA ZYDIS 15 MG TABLET?
ZYPREXA ZYDIS 15 MG TABLET (NDC 00002445585) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.